Literature DB >> 12974504

Factors affecting gallbladder motility: drugs.

L Marzio1.   

Abstract

Various drugs and medications that inhibit or stimulate gallbladder contraction and basal tone in humans are described. Active gallbladder contraction may be achieved using synthetic hormones such as cholecystokinin, caerulein and motilin, cholinomimetic drugs such as bethanecol, prostigmine, and erythromycin due to its motilin-like effect. Furthermore, cisapride and cholestyramine, may have some excitatory activity on the gallbladder muscle. Intravenous amino acids also induce gallbladder contraction through the release of cholecystokinin. Inhibition of gallbladder contraction induced by a meal, or reduction of the basal fasting tone may be achieved by using atropine and other cholinergics, and by inhibitory hormones such as somatostatin, the nitric acid releaser arginine, the calcium channel antagonist nifedipine, and progesterone. Other drugs such as trimebutine, loperamide and ondansetron may negatively affect gallbladder contraction.

Entities:  

Mesh:

Year:  2003        PMID: 12974504     DOI: 10.1016/s1590-8658(03)00088-4

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  5 in total

1.  Research Letter: Anticholinergic Drugs and the Gallbladder -A Neglected Effect?

Authors:  Gary D Friedman; Ninah Achacoso; Laurel A Habel
Journal:  Perm J       Date:  2017

Review 2.  Therapeutic roles of curcumin: lessons learned from clinical trials.

Authors:  Subash C Gupta; Sridevi Patchva; Bharat B Aggarwal
Journal:  AAPS J       Date:  2012-11-10       Impact factor: 4.009

3.  Vitamin-D Deficiency Is Associated with Gallbladder Stasis Among Pregnant Women.

Authors:  Rimpi Singla; Usha Dutta; Neelam Aggarwal; Sanjay Kumar Bhadada; Rakesh Kochhar; Lakhbir K Dhaliwal
Journal:  Dig Dis Sci       Date:  2015-05-12       Impact factor: 3.199

4.  Efficacy and safety of endoscopic retrograde cholangiopancreatography in pregnancy: A high-volume study with long-term follow-up.

Authors:  Buğra Tolga Konduk; Onur Bayraktar
Journal:  Turk J Gastroenterol       Date:  2019-09       Impact factor: 1.852

5.  Curcuma longa L. as a therapeutic agent in intestinal motility disorders. 2: Safety profile in mouse.

Authors:  Matteo Micucci; Rita Aldini; Monica Cevenini; Carolina Colliva; Silvia Spinozzi; Giulia Roda; Marco Montagnani; Cecilia Camborata; Luca Camarda; Alberto Chiarini; Giuseppe Mazzella; Roberta Budriesi
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.